Trial Profile
A pilot study of interferon alpha 2b plus ribavirin in the treatment of patients with chronic hepatitis B.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 29 Mar 2007 New trial record.